Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The yield on cost (YOC) is 3.83%.
YIELD ON COST (YOC)
3.83%
NVO now pays $1.80 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 10 years ago(2016-07-26) | $28.15 | 6.39% |
| 5 years ago(2021-08-03) | $46.56 | 3.87% |
| 3 years ago(2023-08-04) | $78.30 | 2.30% |
| 1 year ago(2025-07-29) | $53.94 | 3.34% |
| Buying today(at $47.08) | $47.08 | 3.83% |
Projection: starting from today's 3.83% yield, assuming the dividend keeps compounding at its historical 10.6% rate. Boards set dividends each year, so actual figures will differ.
Today
3.83%
In 3 years
5.82%
In 5 years
7.70%
In 10 years
15.51%
Try your own purchase price, dividend and growth rate for Novo Nordisk A/S (NVO).
Starting Yield
3.82%
Ending YOC
17.28%
Year 15 Dividend
$8.14
Cum. Dividends Recd.
$66.22
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $1.80 | N/A | 3.82% | $0.00 |
| Year 1 | $1.99 | +10.58% | 4.23% | $1.99 |
| Year 2 | $2.20 | +10.58% | 4.68% | $4.19 |
| Year 3 | $2.43 | +10.58% | 5.17% | $6.63 |
| Year 4 | $2.69 | +10.58% | 5.72% | $9.32 |
| Year 5 | $2.98 | +10.58% | 6.32% | $12.29 |
| Year 6 | $3.29 | +10.58% | 6.99% | $15.58 |
| Year 7 | $3.64 | +10.58% | 7.73% | $19.22 |
| Year 8 | $4.02 | +10.58% | 8.55% | $23.25 |
| Year 9 | $4.45 | +10.58% | 9.45% | $27.70 |
| Year 10 | $4.92 | +10.58% | 10.45% | $32.62 |
| Year 11 | $5.44 | +10.58% | 11.56% | $38.06 |
| Year 12 | $6.02 | +10.58% | 12.78% | $44.08 |
| Year 13 | $6.65 | +10.58% | 14.13% | $50.73 |
| Year 14 | $7.36 | +10.58% | 15.63% | $58.09 |
| Year 15 | $8.14 | +10.58% | 17.28% | $66.22 |
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
